- Home
- HRTG vs AKBA Comparison
HRTG vs AKBA Comparison
Compare HRTG & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HRTG | AKBA |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 898.0M | 729.1M |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HRTG | AKBA |
|---|---|---|
| Price | $24.63 | $1.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $32.50 | $5.92 |
| AVG Volume (30 Days) | 242.0K | ★ 3.5M |
| Earning Date | 03-10-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 98.61 | N/A |
| EPS | ★ 4.83 | N/A |
| Revenue | ★ $842,277,000.00 | $225,071,000.00 |
| Revenue This Year | $5.45 | $52.41 |
| Revenue Next Year | $7.27 | $21.57 |
| P/E Ratio | $5.14 | ★ N/A |
| Revenue Growth | 6.12 | ★ 32.49 |
| 52 Week Low | $9.89 | $1.20 |
| 52 Week High | $31.98 | $4.08 |
Technical Indicators
Market Signals| Indicator | HRTG | AKBA |
|---|---|---|
| Relative Strength Index (RSI) | 37.01 | 34.58 |
| Support Level | $24.23 | $1.33 |
| Resistance Level | $25.87 | $1.60 |
| Average True Range (ATR) | 1.02 | 0.10 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 21.71 | 12.22 |
Price Performance
Historical ComparisonAbout HRTG Heritage Insurance Holdings Inc.
Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.
About AKBA Akebia Therapeutics Inc.
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.